Success Stories: An Indian Research Associate II in Pharmacology Get EB1-A Status Confirmation in Just 12 Days, Thanks to Our Team’s Excellent Work
Client’s Testimonial:
“Thank you so much for sharing this news. I really appreciate your help in advancing my career in the U.S.”
On May 24th, 2022, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Associate II in the Field of Pharmacology (Approval Notice).
General Field: Pharmacology
Position at the Time of Case Filing: Research Associate II
Country of Origin: India
State of Residence at the Time of Filing: Pennsylvania
Approval Notice Date: May 24th, 2022
Processing Time: 12 days (Premium Processing Requested)
Case Summary:
The EB1-A or Alien of Extraordinary Ability is a kind of employment-based, first-preference visa if you are a noncitizen of extraordinary ability. So, for clients who come to NAILG seeking help with their EB1-A case, our team ensures that they collect every relevant data that could help prove the extraordinary ability of the client. So when a leading cardiovascular and integrative physiology expert in pharmacology came to us for her EB1- A case we ensured the same for her.
Our team searched and found the following data:
- The client has achieved a consistent and notable record of success and influence in the chosen study area. She is especially well-known for her work to uncover the role of nitric oxide signaling in acidosis. Furthermore, her work has revolutionized our understanding of cardiac and renal pathophysiology.
- The client has spent years investigating cardiovascular pharmacology and integrative physiology issues and is regarded as an authority in the field. The field has recognized her authority by inviting her to review and evaluate the work of her peers no fewer than 59 times.
- Her work has resulted in 22 peer-reviewed scientific articles and 1 book chapter accepted for publication.
- These publications have been cited 207 times by researchers in at least 24 countries according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of pharmacology.
- Her study has been supported by funding from the National Institutes of Health indicating that her work is nationally significant.
- Finally, her work as a research associate with a Ph.D. in veterinary pharmacology and toxicology has been recognized and praised by 5 recommenders who wrote letters of support for her. One of these experts said:
“[Client’s] research has noticeably improved general knowledge of the pathophysiology of anorectal disorders such as anorectal incontinence, anal fissures, and hemorrhoids. [Client’s] research is valuable to this endeavor because she has identified several therapeutic targets to treat smooth muscle dysfunction due to aging. Her findings have enabled medical researchers to develop specific and rational therapeutic methods for treating anorectal incontinence in the elderly. Given [the client’s] unique methods and accomplished background in pharmacology, the continuation of her work in the United States is essential to maintaining the quality of life of the aging population.”
So, when her approval came through only 12 days after filing, we were happy to have seen her case through to approval. The premium processing upgrade was also helpful in getting the approval quickly. We wish her all the best in her future endeavors.